Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-21 · accession 0001193125-26-021164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-23 | 2026-01-21 | PHAT | Breedlove Robert Charles | Principal Accounting Off | F - Tax | $13.61 | -776 | 47.1K | -2% | -$10.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-21 | F | D | 776 | $13.61 | 47,068 | D | — | — |